KMT2D and cancer: The KMT2 family member KMT2D, which regulates the H3K4me methylation landscapes predominantly at enhancers, has been implicated in the development of cancer by dysregulation of enhancer activity and subsequent disruption of normal development programs [23,24,25,26].